PFIZER INC shareholders Q1 2022

PFIZER INC's ticker is PFE and the CUSIP is 717081103. A total of 3,152 filers reported holding PFIZER INC in Q1 2022. The put-call ratio across all filers is 1.03 and the average weighting 0.6%.

PFIZER INC shareholders Q1 2022
NameSharesValueWeighting ↓
Bill Few Associates, Inc. 75,367$3,902,0002.12%
LONDON CO OF VIRGINIA 7,694,593$398,349,0002.10%
BEDDOW CAPITAL MANAGEMENT INC 76,623$3,967,0002.09%
GFS Advisors, LLC 190,188$9,846,0002.07%
BONNESS ENTERPRISES INC 86,608$4,484,0002.06%
VALLEY WEALTH MANAGERS, INC. 476,313$24,659,0002.06%
Mystic Asset Management, Inc. 73,881$3,824,0002.06%
First National Bank of Mount Dora, Trust Investment Services 131,757$6,821,0002.06%
Community Bank & Trust, Waco, Texas 138,358$7,163,0002.05%
HM PAYSON & CO 1,739,910$90,076,0002.05%
Providence Capital Advisors, LLC 161,747$8,357,0002.05%
Cladis Investment Advisory, LLC 40,980$2,122,0002.03%
Timber Creek Capital Management LLC 129,337$6,695,0002.03%
Holloway Wealth Management, LLC 136,936$7,089,0002.03%
Town & Country Bank & Trust CO dba First Bankers Trust CO 84,150$4,356,0002.03%
Axiom Investment Management LLC 17,944$927,0002.02%
ALLEN HOLDING INC /NY 300,000$15,531,0002.01%
HOLDERNESS INVESTMENTS CO 116,372$6,025,0002.01%
Wahed Invest LLC 65,747$3,404,0002.00%
Next Level Private LLC 47,760$2,473,0002.00%
About PFIZER INC

Pfizer Inc. is a global pharmaceutical company that has been in operation for over 170 years. The company is headquartered in New York City and has a presence in over 150 countries worldwide. Pfizer is known for its innovative research and development of drugs that have helped to improve the lives of millions of people around the world.

One of Pfizer's most well-known products is Viagra, a drug used to treat erectile dysfunction. However, the company has a much broader portfolio of products that includes treatments for cancer, cardiovascular disease, and rare diseases. Pfizer has also been at the forefront of the fight against COVID-19, developing a vaccine that has been authorized for emergency use in many countries.

Pfizer's success can be attributed to its commitment to research and development. The company invests heavily in R&D, with over $8 billion spent in 2020 alone. This investment has led to the development of many groundbreaking drugs, including Lipitor, the best-selling drug of all time.

Despite its success, Pfizer faces challenges in the form of competition from other pharmaceutical companies and the ongoing COVID-19 pandemic. However, the company's strong financial position and commitment to innovation make it well-positioned to continue to thrive in the years to come.

In conclusion, Pfizer Inc. is a global pharmaceutical company that has been at the forefront of drug development for over 170 years. The company's commitment to research and development has led to the development of many groundbreaking drugs, and its recent success in the fight against COVID-19 has further cemented its position as a leader in the industry.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

External links

This page lists PFIZER INC's shareholders in Q1 2022. To view PFIZER INC's shareholder history, click here.